You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cemiplimab

Showing 1 - 25 of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced NSCLC Trial (BNT116, Cemiplimab)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jan 3, 2023

Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Mar 27, 2023

NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Mar 23, 2023

Colon Cancer Trial in Houston (Cemiplimab)

Not yet recruiting
  • Colon Cancer
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2023

Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

Recruiting
  • Hormone Receptor-positive Breast Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Cemiplimab
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Dec 20, 2022

Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

Active, not recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +3 more
Jan 13, 2023

Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

Not yet recruiting
  • Advanced Dedifferentiated Liposarcoma
  • +5 more
  • (no location specified)
Jan 11, 2023

Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)

Not yet recruiting
  • Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

Not yet recruiting
  • Lung Cancer
  • Cemiplimab
  • Kevzara (Sarilumab)
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Melanoma Trial in Orlando, Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Orlando, Florida
  • +1 more
Jul 5, 2022

NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center
May 22, 2023

Cemiplimab to Historical Standard of Care in France

Recruiting
  • Cancer/Squamous Cell Carcinoma of Skin
  • Cemiplimab
  • France, France
    (unnamed)
Jun 6, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Cemiplimab
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 6, 2022

NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Buderim, Queensland, Australia
  • +1 more
Jul 5, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

Recruiting
  • Secondary Angiosarcoma
  • +2 more
  • Cemiplimab
  • Nijmegen, Netherlands
    RadboudUMC
Jan 19, 2022

Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

Recruiting
  • Solid Tumor, Adult
  • +19 more
  • SNS-101 (anti-VISTA)
  • Cemiplimab
  • Irving, Texas
  • +2 more
May 24, 2023

Advanced Solid Tumors Trial in United States (REGN7075, cemiplimab)

Recruiting
  • Advanced Solid Tumors
  • San Francisco, California
  • +9 more
Jan 30, 2023

NSCLC Trial (Cemiplimab)

Recruiting
  • Non-small Cell Lung Cancer
  • Cemiplimab
  • Konstanz, Baden-Württemberg, Germany
  • +8 more
Jan 6, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (REGN5668, Cemiplimab, REGN4018)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +7 more
Sep 26, 2022

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

HPV-Related Squamous Cell Carcinoma Trial in Baltimore (Cemiplimab)

Recruiting
  • HPV-Related Squamous Cell Carcinoma
  • Cemiplimab
  • Baltimore, Maryland
    Johns Hopkins University
Jan 10, 2022